НовостиBenzingaHC Wainwright & Co. Initiates Coverage On MBX Biosciences with Buy Rating, Announces Price Target of $90 HC Wainwright & Co. Initiates Coverage On MBX Biosciences with Buy Rating, Announces Price Target of $90 Benzinga 2026.11.12 11:12 (GMT+0) Открыть на Benzinga Другие новости